SAKAR HEALTHCARE Latest Share Price (SAKAR)
TODAY IN ONE LINE
SAKAR dropped 4.0% on light volume, lagging Nifty's -1.1% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹2,046.55 Cr., it trades at a P/E of 56.71. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
SAKAR HEALTHCARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 87.2% YoY
- ●Healthy Operating MarginsOPM is structurally strong at 18.9%
- ●High Promoter HoldingPromoters hold 51.7% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.26x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 59.1x
- ●Promoter SellingPromoter holding decreased by 0.82% QoQ
Latest SAKAR HEALTHCARE News
What changed recently?
Recent events, corporate actions, and announcements.
SAKAR HEALTHCARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for SAKAR HEALTHCARE, framed against the sector median so the premium or discount is obvious at a glance.
SAKAR HEALTHCARE trades at a P/E of 56.71× and P/B of 6.31×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
SAKAR HEALTHCARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for SAKAR HEALTHCARE — derived from the latest tape, not yesterday's close.
SAKAR HEALTHCARE last traded at ₹923.2 with an intraday range of ₹915–₹968.9 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹923.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1064.20 | +141.00 | +15.27% |
| R3 | 1010.30 | +87.10 | +9.43% |
| R2 | 989.60 | +66.40 | +7.19% |
| R1 | 956.40 | +33.20 | +3.60% |
| PIVOT | 935.70 | 12.50 | 1.35% |
| CURRENT | 923.20 | — | — |
| S1 | 902.50 | -20.70 | -2.24% |
| S2 | 881.80 | -41.40 | -4.48% |
| S3 | 848.60 | -74.60 | -8.08% |
| S4 | 794.70 | -128.50 | -13.92% |
SAKAR is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹949.6–₹968.9
Trading Below opening range, showing Bearishness
SAKAR HEALTHCARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for SAKAR HEALTHCARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
SAKAR HEALTHCARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,046.55 Cr. and reported EPS of ₹4.62.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 252 | 252 ▲ 0.0% |
| Sales Growth YoY %Derived | 41.76% | — |
| Other Income | 2 | 2 ▲ 0.0% |
| Total Income | 254 | 254 ▲ 0.0% |
| 123 | 123 ▲ 0.0% | |
| Gross ProfitDerived | 128 | 128 ▲ 0.0% |
| Gross Margin %Derived | 51.03% | 51.03% |
| 60 | 60 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 69 | 69 ▲ 0.0% |
| OPM %Derived | 27.37% | 27.37% |
| 31 | 31 ▲ 0.0% | |
| Profit Before Tax (PBT) | 40 | 40 ▲ 0.0% |
| 9 | 9 ▲ 0.0% | |
| Effective Tax %Derived | 23.32% | 23.32% |
| Total Profit for Period | 30 | 30 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 30 | 30 ▲ 0.0% |
| Net Profit Margin %Derived | 12.11% | 12.11% |
| PAT Growth YoY %Derived | 74.18% | — |
| Earnings Per Share (EPS ₹) | 13.70 | 13.70 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 214 | 214 ▲ 0.0% |
| Material Cost % of RevenueDerived | 52.71% | 52.71% |
| Employee Cost % of RevenueDerived | 15.38% | 15.38% |
| Other Cost % of RevenueDerived | 8.28% | 8.28% |
| Interest Coverage (x)Derived | 5.77x | 5.77x |
| Period | Mar 2021 | Jun 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | Apr 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 95 | 95 ▲ 0.0% | 128 ▲ 35.3% | 128 ▲ 0.0% | 133 ▲ 4.0% | 133 ▲ 0.0% | 153 ▲ 15.0% | 153 ▲ 0.0% | 178 ▲ 15.8% | 178 ▲ 0.0% | 252 ▲ 41.8% | 252 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 35.35% | — | 4.00% | 4.00% | 14.99% | 14.99% | 15.80% | — | 41.76% | — | |
| Other Income | 1 | 1 ▲ 0.0% | 2 ▲ 84.7% | 2 ▲ 0.0% | 5 ▲ 115.3% | 5 ▲ 0.0% | 3 ▼ 32.0% | 3 ▲ 0.0% | 1 ▼ 58.7% | 1 ▲ 0.0% | 2 ▲ 74.3% | 2 ▲ 0.0% | |
| Total Income | 96 | 96 ▲ 0.0% | 130 ▲ 36.0% | 130 ▲ 0.0% | 138 ▲ 5.9% | 138 ▲ 0.0% | 157 ▲ 13.4% | 157 ▲ 0.0% | 179 ▲ 14.3% | 179 ▲ 0.0% | 254 ▲ 42.0% | 254 ▲ 0.0% | |
51 | 51 ▲ 0.0% | 74 ▲ 45.6% | 74 ▲ 0.0% | 74 ▼ 1.2% | 74 ▲ 0.0% | 84 ▲ 13.8% | 84 ▲ 0.0% | 82 ▼ 1.7% | 82 ▲ 0.0% | 123 ▲ 49.9% | 123 ▲ 0.0% | ||
| Gross ProfitDerived | 44 | 44 ▲ 0.0% | 54 ▲ 23.3% | 54 ▲ 0.0% | 60 ▲ 11.2% | 60 ▲ 0.0% | 70 ▲ 16.5% | 70 ▲ 0.0% | 95 ▲ 36.8% | 95 ▲ 0.0% | 128 ▲ 34.8% | 128 ▲ 0.0% | |
| Gross Margin %Derived | 46.05% | 46.05% | 41.96% | 41.96% | 44.85% | 44.85% | 45.43% | 45.43% | 53.68% | 53.68% | 51.03% | 51.03% | |
21 | 21 ▲ 0.0% | 24 ▲ 16.4% | 24 ▲ 0.0% | 27 ▲ 9.0% | 27 ▲ 0.0% | 31 ▲ 17.4% | 31 ▲ 0.0% | 46 ▲ 45.8% | 46 ▲ 0.0% | 60 ▲ 30.5% | 60 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 23 | 23 ▲ 0.0% | 29 ▲ 29.8% | 29 ▲ 0.0% | 33 ▲ 13.0% | 33 ▲ 0.0% | 38 ▲ 15.8% | 38 ▲ 0.0% | 50 ▲ 29.5% | 50 ▲ 0.0% | 69 ▲ 38.7% | 69 ▲ 0.0% | |
| OPM %Derived | 23.85% | 23.85% | 22.87% | 22.87% | 24.85% | 24.85% | 25.02% | 25.02% | 27.98% | 27.98% | 27.37% | 27.37% | |
11 | 11 ▲ 0.0% | 13 ▲ 19.2% | 13 ▲ 0.0% | 21 ▲ 66.6% | 21 ▲ 0.0% | 26 ▲ 22.5% | 26 ▲ 0.0% | 29 ▲ 14.5% | 29 ▲ 0.0% | 31 ▲ 7.0% | 31 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 13 | 13 ▲ 0.0% | 19 ▲ 43.1% | 19 ▲ 0.0% | 17 ▼ 10.9% | 17 ▲ 0.0% | 16 ▼ 5.8% | 16 ▲ 0.0% | 22 ▲ 35.4% | 22 ▲ 0.0% | 40 ▲ 84.7% | 40 ▲ 0.0% | |
3 | 3 ▲ 0.0% | 4 ▲ 47.1% | 4 ▲ 0.0% | 4 ▲ 9.7% | 4 ▲ 0.0% | 4 ▲ 2.7% | 4 ▲ 0.0% | 4 ▼ 4.8% | 4 ▲ 0.0% | 9 ▲ 130.3% | 9 ▲ 0.0% | ||
| Effective Tax %Derived | 19.27% | 19.27% | 19.82% | 19.82% | 24.40% | 24.40% | 26.60% | 26.60% | 18.70% | 18.70% | 23.32% | 23.32% | |
| Total Profit for Period | 11 | 11 ▲ 0.0% | 15 ▲ 42.1% | 15 ▲ 0.0% | 13 ▼ 16.0% | 13 ▲ 0.0% | 12 ▼ 8.5% | 12 ▲ 0.0% | 18 ▲ 50.0% | 18 ▲ 0.0% | 30 ▲ 74.2% | 30 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 11 | 11 ▲ 0.0% | 15 ▲ 42.1% | 15 ▲ 0.0% | 13 ▼ 16.0% | 13 ▲ 0.0% | 12 ▼ 8.5% | 12 ▲ 0.0% | 18 ▲ 50.0% | 18 ▲ 0.0% | 30 ▲ 74.2% | 30 ▲ 0.0% | |
| Net Profit Margin %Derived | 11.28% | 11.28% | 11.84% | 11.84% | 9.57% | 9.57% | 7.61% | 7.61% | 9.86% | 9.86% | 12.11% | 12.11% | |
| PAT Growth YoY %Derived | — | — | 42.10% | — | -15.95% | -15.95% | -8.53% | -8.53% | 49.96% | — | 74.18% | — | |
| Earnings Per Share (EPS ₹) | 6.84 | 6.84 ▲ 0.0% | 8.73 ▲ 27.6% | 8.73 ▲ 0.0% | 6.70 ▼ 23.3% | 6.70 ▲ 0.0% | 5.37 ▼ 19.9% | 5.37 ▲ 0.0% | 7.97 ▲ 48.4% | 7.97 ▲ 0.0% | 13.70 ▲ 71.9% | 13.70 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% | 2 ▲ 9.6% | 2 ▲ 0.0% | 2 ▲ 11.2% | 2 ▲ 0.0% | 2 ▲ 14.2% | 2 ▲ 0.0% | 2 ▲ 0.9% | 2 ▲ 0.0% | 2 ▲ 1.4% | 2 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% | -0 ▼ 602.8% | -0 ▲ 0.0% | -0 ▲ 8.7% | -0 ▲ 0.0% | -0 ▲ 49.8% | -0 ▲ 0.0% | -0 ▼ 9.5% | -0 ▲ 0.0% | -0 ▲ 8.8% | -0 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 83 | 83 ▲ 0.0% | 111 ▲ 34.8% | 111 ▲ 0.0% | 121 ▲ 8.7% | 121 ▲ 0.0% | 141 ▲ 16.1% | 141 ▲ 0.0% | 157 ▲ 11.9% | 157 ▲ 0.0% | 214 ▲ 36.2% | 214 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 54.91% | 54.91% | 57.32% | 57.32% | 55.42% | 55.42% | 55.46% | 55.46% | 53.76% | 53.76% | 52.71% | 52.71% | |
| Employee Cost % of RevenueDerived | 14.00% | 14.00% | 11.87% | 11.87% | 12.57% | 12.57% | 12.90% | 12.90% | 17.82% | 17.82% | 15.38% | 15.38% | |
| Other Cost % of RevenueDerived | 8.20% | 8.20% | 7.22% | 7.22% | 7.43% | 7.43% | 7.52% | 7.52% | 7.88% | 7.88% | 8.28% | 8.28% | |
| Interest Coverage (x)Derived | 5.86x | 5.86x | 6.79x | 6.79x | 3.05x | 3.05x | 2.68x | 2.68x | 3.37x | 3.37x | 5.77x | 5.77x |
SAKAR HEALTHCARE segment analysis : revenue and profit mix.
Disclosed business segments at SAKAR HEALTHCARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
SAKAR HEALTHCARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for SAKAR HEALTHCARE.
Our AI distills the core fundamental drivers supporting SAKAR HEALTHCARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 74 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
SAKAR HEALTHCARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — SAKAR HEALTHCARE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
SAKAR HEALTHCARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for SAKAR HEALTHCARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
SAKAR HEALTHCARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for SAKAR HEALTHCARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in SAKAR HEALTHCARE stood at 48.8% of traded volume, against a 20-day average of 47.7%.
SAKAR HEALTHCARE announcements: results, concalls, ratings, M&A.
Filings SAKAR HEALTHCARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
SAKAR HEALTHCARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 95 documents below.
General Updates
Sakar Healthcare Limited has informed the Exchange about Sakar s global export model expands with oncology products
General Updates
Sakar Healthcare Limited has informed the Exchange about Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations,…
Trading Window
Sakar Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Appointment
Sakar Healthcare Limited has informed the Exchange regarding Appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors of the Company…
Shareholders meeting
Sakar Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the…
Investor decks & rating reports.
SAKAR HEALTHCARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue SAKAR HEALTHCARE has declared, sequenced by announce and record date.
SAKAR HEALTHCARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
SAKAR HEALTHCARE insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in SAKAR HEALTHCARE as reported to SEBI — buying and selling signals from the people who know the business best.
SAKAR HEALTHCARE insider activity below tracks 2 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Aarsh S. Shah | Insider | 27 Dec 2024 | buy | +1.00 L | ₹2.88 Cr. | ₹288.00 |
| Sanjay S. Shah | Insider | 27 Dec 2024 | buy | +1.00 L | ₹2.88 Cr. | ₹288.00 |
About SAKAR HEALTHCARE: business, sector, key facts.
What SAKAR HEALTHCARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
SAKAR HEALTHCARE operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: SAKAR.
Sakar Healthcare Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and marketing of a diverse range of pharmaceutical products. Their operations encompass the entire production process, from initial research and development to final product marketing and distribution. The company's commitment to a wide spectrum of therapeutic areas allows them to cater to a broad patient base and market demand.
The company's product portfolio is extensive and includes various dosage forms to accommodate diverse patient needs and treatment preferences. These forms include liquid orals, tablets, capsules, dry powder syrups, dry powder injections, liquid injectables (SVP) in ampoules and vials, lyophilized injections, and oral solid dosages. This breadth of dosage forms allows for flexibility in administration and potentially improved patient compliance.
Sakar Healthcare's product offerings span a considerable number of therapeutic areas, indicating a wide range of medical conditions addressed by their formulations. These areas include antacids, antimalarials, anticoagulants, laxatives, anthelmintics, bronchodilators, anesthetics, antidepressants, sedatives, adrenergics, anti-infectives, diuretics, oxytocics, analgesics, antiemetics, antipsychotics, antifungals, PPIs, anticonvulsants, anti-inflammatories, antihistamines, and multivitamins. This diversified portfolio demonstrates a commitment to serving a wide range of patient needs.
Beyond the domestic Indian market, Sakar Healthcare actively participates in international trade, exporting its products to several key regions globally. These export destinations encompass Southeast Asia, other parts of Asia, various African countries (both Anglophone and Francophone), the Middle East and North Africa (MENA) region, and even the United States. This international reach significantly expands the company's market presence and potential for growth.
Established in 2004 and headquartered in Ahmedabad, India, Sakar Healthcare Limited has a history of providing pharmaceutical solutions. Their integrated approach, encompassing research, development, manufacturing, and marketing, positions them as a significant player within the Indian pharmaceutical industry and beyond, through its international exports. The company's success rests on its broad product portfolio, diverse therapeutic coverage, and global market reach.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Top Losers TodayScreener
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about SAKAR HEALTHCARE (SAKAR).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of SAKAR HEALTHCARE (SAKAR)?
The current share price of SAKAR HEALTHCARE (SAKAR) is ₹923.20. Today, the stock has declined by ₹38.50 (4%), trading in a range of ₹915.00 to ₹968.90. The stock opened at ₹952.50 with a trading volume of 66,081 shares.
02Is SAKAR HEALTHCARE stock a good investment for long-term?
SAKAR HEALTHCARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,046.55 Cr., P/E ratio of 56.71, ROE of 10.68%, and ROCE of 10.13%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of SAKAR HEALTHCARE stock?
The 52-week high price of SAKAR HEALTHCARE (SAKAR) is ₹1,229.85, while the 52-week low is ₹350.10. Currently trading at ₹923.20, the stock is 163.7% above its 52-week low and 24.93% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy SAKAR HEALTHCARE stock at the current price?
Whether to buy SAKAR HEALTHCARE stock at ₹923.20 depends on multiple factors. The stock is currently trading with a P/E ratio of 56.71 and P/B ratio of 6.31. Today's performance shows a loss of 4%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of SAKAR HEALTHCARE and when is the next dividend?
SAKAR HEALTHCARE offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹923.20, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of SAKAR HEALTHCARE?
SAKAR HEALTHCARE's key financial metrics include: P/E Ratio: 56.71, P/B Ratio: 6.31, ROE: 10.68%, ROCE: 10.13%, Dividend Yield: 0%, EPS: ₹4.62, Book Value: ₹128.30, and Debt-to-Equity: 0.26. The company's market cap stands at ₹2,046.55 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is SAKAR HEALTHCARE stock performing today in the market?
SAKAR HEALTHCARE stock opened at ₹952.50 and is currently trading at ₹923.20, showing a decline of ₹38.50 (4%). The intraday high is ₹968.90 and low is ₹915.00. The trading volume stands at 66,081 shares, indicating moderate market participation today.
08What is the P/E ratio of SAKAR HEALTHCARE and what does it indicate?
SAKAR HEALTHCARE has a Price-to-Earnings (P/E) ratio of 56.71, which means investors are willing to pay 56.71 for every ₹1 of earnings. With an EPS of ₹4.62, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about SAKAR HEALTHCARE (SAKAR) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.